Addison’s disease treatment market is growing with advancements in hormone replacement therapies, including glucocorticoids and mineralocorticoids, ensuring better disease management by 2035.

Cena Hermus, 7, was two years old when she was diagnosed with a rare, life-threatening disorder that causes severe obesity.

Addison’s disease is a rare condition in which the adrenal glands do not produce enough of the hormones cortisol and ...

On Dec 12, 2024, the US Food and Drug Administration (FDA) approved crinecerfont for adults and paediatric patients with ...

Vitamin D deficiency (VDD) is independently associated with increased depression risk in patients with chronic kidney disease (CKD).

Persistent fatigue despite a healthy diet and adequate rest may indicate underlying metabolic, endocrine, or neurological ...

TEVIMBRA can cause immune-mediated adrenal insufficiency. For Grade 2 or higher adrenal insufficiency, initiate symptomatic treatment, including hormone replacement as clinically indicated. Withhold ...

Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare ...

Corcept Therapeutics (CORT) announced that the FDA filed its New Drug Application (NDA) submission for its proprietary, selective cortisol ...

Relacorilant was well tolerated. Notably, there were no instances of drug-induced adrenal insufficiency, hypokalemia or QT ...

Adrenal fatigue is slowly becoming a popular idea, with people sharing their experiences online. But why do doctors discredit ...

It wasn’t as if she were wasting away, and she rather liked the way she looked at this new weight. Still, she hadn’t been ...